A multi-biomarker analysis of the antioxidant efficacy of Parkinson's disease therapy. (March 2018)
- Record Type:
- Journal Article
- Title:
- A multi-biomarker analysis of the antioxidant efficacy of Parkinson's disease therapy. (March 2018)
- Main Title:
- A multi-biomarker analysis of the antioxidant efficacy of Parkinson's disease therapy
- Authors:
- Colamartino, Monica
Duranti, Guglielmo
Ceci, Roberta
Sabatini, Stefania
Testa, Antonella
Cozzi, Renata - Abstract:
- Abstract: Substantial evidences suggest that reactive oxygen species participate in the normal aging process and in cancer and neurodegenerative age-related diseases. Parkinson's disease (PD), one of the most common oxidative stress-associated pathology in aging people, is treated with a standard pharmacological protocol consisting in a combined therapyl -dopa plus an inhibitor of dopa-decarboxylase, such as carbidopa. The therapy is well validated for the ability to restoring dopaminergic neurotransmission in PD patients, whilel -dopa and carbidopa ability in modulating oxidative stress is currently under discussion. Our aim was to evaluate the impact ofl -dopa and carbidopa on several biomarkers of exogenously-induced oxidative stress to validate the overall antioxidant effectiveness of the therapy. For this purpose we used peripheral blood lymphocytes from healthy donors treated in vitro withl -dopa and carbidopa and then challenged by different concentrations of H2 O2 . Glutathione (GSH, GSSG, GSH/GSSG), malondialdehyde (TBARs), protein carbonyls as well as DNA damage (8-oxo-7, 8-dihydro-2′-deoxyguanosine (8-oxodG) and micronuclei (MN)), modulation was evaluated. Our results show thatl -dopa, but not carbidopa, decreases the markers of lipid and protein oxidation and increases the total content of glutathione. Bothl -dopa and carbidopa (alone or in combination) are able to counteract the formation of 8-oxodG and to reduce H2 O2 -induced micronuclei. Highlights: l -DopaAbstract: Substantial evidences suggest that reactive oxygen species participate in the normal aging process and in cancer and neurodegenerative age-related diseases. Parkinson's disease (PD), one of the most common oxidative stress-associated pathology in aging people, is treated with a standard pharmacological protocol consisting in a combined therapyl -dopa plus an inhibitor of dopa-decarboxylase, such as carbidopa. The therapy is well validated for the ability to restoring dopaminergic neurotransmission in PD patients, whilel -dopa and carbidopa ability in modulating oxidative stress is currently under discussion. Our aim was to evaluate the impact ofl -dopa and carbidopa on several biomarkers of exogenously-induced oxidative stress to validate the overall antioxidant effectiveness of the therapy. For this purpose we used peripheral blood lymphocytes from healthy donors treated in vitro withl -dopa and carbidopa and then challenged by different concentrations of H2 O2 . Glutathione (GSH, GSSG, GSH/GSSG), malondialdehyde (TBARs), protein carbonyls as well as DNA damage (8-oxo-7, 8-dihydro-2′-deoxyguanosine (8-oxodG) and micronuclei (MN)), modulation was evaluated. Our results show thatl -dopa, but not carbidopa, decreases the markers of lipid and protein oxidation and increases the total content of glutathione. Bothl -dopa and carbidopa (alone or in combination) are able to counteract the formation of 8-oxodG and to reduce H2 O2 -induced micronuclei. Highlights: l -Dopa and carbidopa per se do not induce oxidative stress. Both molecules are able to reduce DNA and chromosome damage induced by H2 O2 . The combined effectl -dopa + carbidopa is more efficient in reducing 8-oxo-dG levels. l -Dopa in single and combined treatments restores the redox status of cells and reduces lipid and protein oxidation. … (more)
- Is Part Of:
- Toxicology in vitro. Volume 47(2018)
- Journal:
- Toxicology in vitro
- Issue:
- Volume 47(2018)
- Issue Display:
- Volume 47, Issue 2018 (2018)
- Year:
- 2018
- Volume:
- 47
- Issue:
- 2018
- Issue Sort Value:
- 2018-0047-2018-0000
- Page Start:
- 1
- Page End:
- 7
- Publication Date:
- 2018-03
- Subjects:
- PD Parkinson's disease -- l-dopa 3-4 dihydroxy-l-phenylalanine -- PBLs peripheral blood lymphocytes -- ROS reactive oxygen species -- 8-oxodG 8-oxo-7, 8-dihydro-2′-deoxyguanosine -- MN micronuclei -- TBARS thiobarbituric acid-reactive substances -- PrCAR protein carbonyls -- GSH reduced glutathione -- GSSG oxidized glutathione
l-Dopa -- Carbidopa -- Oxidative stress -- DNA damage -- Lipid/protein oxidation markers -- Glutathione
Toxicity testing -- In vitro -- Periodicals
Toxicology -- Periodicals
615.9 - Journal URLs:
- http://www.sciencedirect.com/science/journal/08872333 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.tiv.2017.10.020 ↗
- Languages:
- English
- ISSNs:
- 0887-2333
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8873.043400
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 5808.xml